Class-specific sensing of HIV-1 antigens by the B cell antigen receptor depends on the CH1 domain
Yaneth M. OrtiziD, Kara M. AnastiiD, Advaiti Pai KaneiD, Kenneth D. CroniniD, S. Munir AlamiD, Michael G. RethiD
Abstract
How different classes of the B cell antigen receptor (BCR) sense viral antigens used in vaccination protocols is poorly understood. Here we study antigen binding and sensing of Ramos B cells expressing BCRs of either the IgM or IgG1 class with a specificity for the CD4-binding-site of the envelope (Env) protein of the human immune deficiency virus-1 (HIV-1). We find that, in spite of their identical antigen binding site, the two BCR classes differ drastically from each other in that the IgM-BCR and IgG1-BCR bind preferentially to monovalent and polyvalent antigens, respectively. By generating an IgM/IgG1 chimeric BCR we found that the class-specific antigen-sensing behavior can be transferred with the CH1{gamma} domain from the IgG1-BCR to the IgM-BCR. Our results indicate that the class-switching process not only results in the production of antibody classes with different effector functions but also alters the antigen sensing of secondary B lymphocytes. These findings suggest that antigen valency in existing vaccination protocols should be modified and altered between primary versus secondary (booster) immunization.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 0.45
- Field percentile
- top 47%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Anti-HIV-1 B cell antigen receptor signaling and structure
Bhishem Thakur, Jahangir Alam, … S. Munir Alam·iSciencePeer-reviewed·Nov 1, 2026
- Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain
M. D. Gray, J. Feng, … L. Stamatatos·bioRxiv·Aug 21, 2021
- Increased immunogen valency improves the maturation of vaccine-elicited HIV-1 VRC01-class antibodies
Parul Agrawal, Arineh Khechaduri, … Leonidas Stamatatos·bioRxiv·Mar 13, 2025
- Sequential vaccination matures VRC01-class HIV-1 neutralizing antibodies in humans
Tom G. Caniels, Madhu S. Prabhakaran, … Rogier W. Sanders·bioRxiv·Oct 26, 2026
- B cells discriminate HIV-1 Envelope protein affinities by sensing antigen binding association rates
M. A. Hossain, K. Anasti, … S. M. Alam·bioRxiv·Jan 14, 2022
- Maturation of HIV-1 neutralizing antibodies in a germinal center conditional expression mouse model
Ming Tian, Jillian Davis, … Frederick W. Alt·PLoS PathogensPeer-reviewed·Jun 22, 2026